The study investigates the effect of plasma myeloperoxidase (MPO) concentrations on HDL dysfunction during the acute stage of ischemic and haemorrhagic strokes.
MRI or CT scan are used to confirm the diagnosis of haemorrhagic, ischemic and mimick stroke. Plasma anf HDL-MPO concentrations, as well as potent HDL dysfunction, are compared in the 3 cases. The investigators hypothesis is that MPO concentrations and subsequent HDL dysfunction could be higher in ischemic strokes than in haemorrhagic ones. MPO could be a examined as a potent marker of early stage of ischemic stroke. Plasma MPO levels could also be discriminant regarding the mimick strokes in patient exhibiting stroke clinical picture.
Study Type
OBSERVATIONAL
Enrollment
112
Patients with acute stage of stroke clinical picture, with ischemic, haemorrhagic or mimick stroke diagnosed using MRI or CT scan
Patients with acute stage of stroke clinical picture, with ischemic, haemorrhagic or mimick stroke diagnosed using MRI or CT scan
Chu Reunion Island
Saint-Pierre, Reunion Island, Reunion
RECRUITINGPlasma MPO concentrations
Assessment of plasma MPO concentrations during acute stage of stroke
Time frame: Through study completion, an average of 6 hours
HDL-MPO concentrations
Assessment of HDL-MPO concentrations during acute stage of stroke
Time frame: Through study completion, an average of 6 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.